Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Starting insulin therapy in type 2 diabetes: lesson 1.

× No keyword cloud information.

12 in total

Review 1. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association.

Authors: Richard W Nesto; David Bell; Robert O Bonow; Vivian Fonseca; Scott M Grundy; Edward S Horton; Martin Le Winter; Daniel Porte; Clay F Semenkovich; Sidney Smith; Lawrence H Young; Richard Kahn
Journal: Diabetes Care Date: 2004-01 Impact factor: 19.112

Review 2. The use of bolus insulin and advancing insulin therapy in type 2 diabetes.

Authors: Diane M Karl
Journal: Curr Diab Rep Date: 2004-10 Impact factor: 4.810

3. Starting insulin therapy in type 2 diabetic patients: does it really matter how?

Authors: Mayer B Davidson
Journal: Diabetes Care Date: 2005-02 Impact factor: 19.112

4. Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.

Authors: Carmine G Fanelli; Simone Pampanelli; Francesca Porcellati; Paolo Rossetti; Paolo Brunetti; Geremia B Bolli
Journal: Ann Intern Med Date: 2002-04-02 Impact factor: 25.391

Review 5. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes.

Authors: P E Cryer
Journal: Diabetologia Date: 2002-04-26 Impact factor: 10.122

6. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

Authors: Matthew C Riddle; Julio Rosenstock; John Gerich
Journal: Diabetes Care Date: 2003-11 Impact factor: 19.112

7. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes.

Authors: Andreas Hamann; Stephan Matthaei; Christoph Rosak; Louise Silvestre
Journal: Diabetes Care Date: 2003-06 Impact factor: 19.112

8. Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes.

Authors: Mary F Carroll; Absalon Gutierrez; Marygrace Castro; Dechen Tsewang; David S Schade
Journal: J Clin Endocrinol Metab Date: 2003-11 Impact factor: 5.958

9. Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group.

Authors: M C Riddle; J Schneider
Journal: Diabetes Care Date: 1998-07 Impact factor: 19.112

10. Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial.

Authors: Andreas Fritsche; Matthias Axel Schweitzer; Hans-Ulrich Häring
Journal: Ann Intern Med Date: 2003-06-17 Impact factor: 25.391